Target Letters in Healthcare Fraud Investigations

Target Letters in Healthcare Fraud Investigations at a Glance

A target letter is a formal notification from federal prosecutors indicating that an individual or entity is under investigation for potential violations of the Anti-Kickback Statute (AKS) or related laws. These letters often serve as a precursor to formal charges and are commonly used in healthcare fraud investigations. They signal that the Department of Justice (DOJ) or the Office of Inspector General (OIG) has identified sufficient evidence to warrant further scrutiny, and they are typically issued within the five-year statute of limitations for criminal AKS violations, as governed by 18 U.S.C. § 3282.

The Legal Framework

The Anti-Kickback Statute, 42 U.S.C. § 1320a-7b(b), prohibits the knowing and willful offer, payment, solicitation, or receipt of remuneration to induce or reward referrals of items or services payable by a federal health care program. This statute is a cornerstone of federal healthcare fraud enforcement and carries severe penalties, including fines of up to $100,000 and imprisonment for up to 10 years, or both. The statute applies broadly, covering a wide range of remuneration types, including financial payments, services, and other benefits.

The general statute of limitations for non-capital federal offenses, including criminal AKS violations, is governed by 18 U.S.C. § 3282, which sets a five-year limit from the date the offense was committed. This period is critical in determining whether an investigation can proceed to indictment and whether evidence remains admissible in court. A target letter is typically issued within this window, signaling that the investigation is active and that the DOJ has identified potential violations that may lead to formal charges.

Enforcement and Cases

Target letters are a common tool in healthcare fraud investigations and frequently precede indictments within the five-year window outlined in 18 U.S.C. § 3282. These letters may be issued by the DOJ, the OIG, or other federal enforcement agencies and are often accompanied by requests for information or cooperation. While no specific cases are cited in this research, the issuance of such letters is a well-documented part of the enforcement process under the AKS and related statutes.

The Federal Overlay

The federal Anti-Kickback Statute, 42 U.S.C. § 1320a-7b(b), makes it a felony to knowingly and willfully offer, pay, solicit, or receive remuneration to induce or reward referrals of items or services payable by a federal health care program. The Stark Law, 42 U.S.C. § 1395nn, separately prohibits physician self-referrals for designated health services payable by Medicare or Medicaid, on strict-liability terms. Both regimes carry safe harbors and exceptions published at 42 C.F.R. § 1001.952. State referral and fee-splitting statutes operate alongside these federal prohibitions and can apply even where no federal program payment is involved.

Reading the Research Desk

For further exploration of related topics, refer to the following pages: /practice-areas/ (the AKS Defense Research Topics desk), /the-anti-kickback-statute-explained-why-referral-payments-trigger-scrutiny/ (the statute explainer), /safe-harbors-under-the-anti-kickback-statute-and-where-providers-get-tripped-up/ (the safe-harbor research note), /aks-and-stark-law-how-the-two-regimes-overlap-in-healthcare-investigations/ (the AKS/Stark overlap analysis), /recent-antikickback-statute-decisions/ (recent decisions), and /faq/ (the FAQ).